The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.715
Bid: 0.65
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.05 (7.692%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.715
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Feb 2011 07:00

RNS Number : 5387B
Ultima Networks PLC
21 February 2011
 



21 February 2011

 

Ultima Networks plc

('Ultima' or the 'Company')

 

Appointment of Executive Director

 

The Board of Ultima is pleased to announce the appointment of Matteo Turi to its Board as an Executive Director of the Company with effect from 1 April 2011. Matteo will be responsible for the development of the Company's Green Power division and specifically for Ultima's solar power activities in Italy.

 

Matteo Turi (aged 39) is currently Finance Director at London-based RenGen Energy Group ("RenGen"), a renewable energy fund which sources, develops and finances renewable energy projects. RenGen's interests include equity and debt investments in renewable energy projects in Italy. Matteo joined RenGen in April 2008 where he has been, inter alia, responsible for all financial strategies and planning for RenGen's renewable energy investments. Matteo will initially continue to work with RenGen on a part-time basis.

 

Prior to joining RenGen, Matteo was European Financial Controller at K2 Partnering Solutions Ltd, a global provider of enterprise software consultants, from May 2007 to April 2008 where his role included business transformation and extensive change management. Previously Matteo was Divisional Financial Controller of Vanco plc, a Pan-European telecoms business, from May 1999 to March 2005 where he helped support the growth of Vanco during this period including the listing in 2001 of the company on the Official List of the London Stock Exchange. After leaving Vanco Matteo worked at International Poster Management, part of the Interpublic Group, as Divisional Financial Controller on a short term project and was Senior Overseas Financial Manager at Moneygram International Ltd where his role covered the integration of a major acquisition. Matteo has been a member of ACCA (the Association of Chartered Certified Accountants) since 2003.

 

Commenting on the board appointment, Prof. Humayun Mughal, the Company's Chairman and CEO, commented: "On behalf of the Board I would like to welcome Matteo onto the board and into his new role further strengthening our renewable energy capabilities. Matteo joins us with experience in the renewable energy sector at a time when we are looking to build upon our solar power credentials, particularly in Italy. We are confident that his experience will prove to be valuable to the growth of Ultima."

 

Matteo Turi is, or has been, a director of the following companies in the last 5 years:

 

Current Directorships/Partnerships:

 

Directorships/Partnerships within the last 5 years:

None

None

 

Matteo currently has no interest in the share capital of Ultima.

 

There are no further disclosures to be made in relation to Mr Matteo Turi under Schedule 2 (g) and rule 17 of the AIM Rules for Companies.

 

 

Ultima Networks plc

Prof. Humayun Mughal, Chairman and CEO

Tel: 01279 821 200

Allenby Capital Limited

(Nominated Adviser and Broker)

Tel: +44 (0)203 328 5656

Nick Naylor

Nick Athanas

Alex Price

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGZZMGVGMZZ
Date   Source Headline
11th Nov 20202:05 pmRNSSecond Price Monitoring Extn
11th Nov 20202:00 pmRNSPrice Monitoring Extension
11th Nov 202011:05 amRNSSecond Price Monitoring Extn
11th Nov 202011:00 amRNSPrice Monitoring Extension
9th Nov 20207:00 amRNSLaunch of Nuvec® Oncology Treatment Programme
5th Nov 20207:00 amRNSOperational Update
30th Sep 20207:00 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSInterim Results
15th Sep 20202:06 pmRNSSecond Price Monitoring Extn
15th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 202011:05 amRNSSecond Price Monitoring Extn
14th Sep 202011:00 amRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSCovid-19 Proof of Concept Update
8th Sep 202011:40 amRNSExercise of Options
2nd Sep 20208:00 amRNSHolding(s) in Company
2nd Sep 20208:00 amRNSTotal Voting Rights
1st Sep 20207:00 amRNSTechnology Transfer and Manufacturing Contract
26th Aug 20203:47 pmRNSExercise of Warrants and Issue of Equity
14th Aug 20202:22 pmRNSExercise of Warrants and Issue of Equity
14th Aug 202011:06 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
12th Aug 20202:00 pmRNSPrice Monitoring Extension
12th Aug 20201:47 pmRNSPositive Covid-19 In Vitro Study Results
27th Jul 202011:05 amRNSSecond Price Monitoring Extn
27th Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 202011:00 amRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSChange of Adviser
6th Jul 20207:00 amRNSWork Programme and Strategic Update
18th Jun 202012:05 pmRNSResult of General Meeting and grant of warrants
1st Jun 202012:28 pmRNSPosting of circular and notice of general meeting
29th May 20205:00 pmRNSTotal Voting Rights
28th May 20209:00 amRNSPrice Monitoring Extension
28th May 20207:00 amRNSCovid-19 Project Update
21st May 20204:26 pmRNSHolding(s) in Company
20th May 202012:29 pmRNSHolding(s) in Company
18th May 20204:41 pmRNSSecond Price Monitoring Extn
18th May 20204:37 pmRNSPrice Monitoring Extension
18th May 20204:29 pmRNSGrant of Options
18th May 20202:25 pmRNSPatent filing update
13th May 20201:58 pmRNSPlacing to raise £2m & appointment of Joint Broker
24th Apr 20207:00 amRNSNew Nuvec® opportunity and patent filing
23rd Apr 202011:01 amRNSResult of AGM
17th Apr 20207:00 amRNSAttendance at the Company's annual general meeting
16th Apr 20207:00 amRNSCovid-19 Project Update
15th Apr 20209:05 amRNSSecond Price Monitoring Extn
15th Apr 20209:00 amRNSPrice Monitoring Extension
30th Mar 20202:05 pmRNSSecond Price Monitoring Extn
30th Mar 20202:00 pmRNSPrice Monitoring Extension
25th Mar 20201:18 pmRNSChanges to AGM
25th Mar 20207:00 amRNSCovid-19 Project Update and operational update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.